Labcorp Holdings EBIT 2010-2025 | LH

Labcorp Holdings EBIT for the quarter ending June 30, 2025 was $0.395B, a 33.82% increase year-over-year.

  • Labcorp Holdings 2024 EBIT was 1.087B, a 49.77% increase from 2023.
  • Labcorp Holdings 2023 EBIT was 0.726B, a 49.49% decline from 2022.
  • Labcorp Holdings 2022 EBIT was 1.437B, a 52.88% decline from 2021.

EBIT can be defined as earnings before interest and taxes.

Labcorp Holdings EBIT 2010-2025 | LH

  • Labcorp Holdings 2024 EBIT was 1.087B, a 49.77% increase from 2023.
  • Labcorp Holdings 2023 EBIT was 0.726B, a 49.49% decline from 2022.
  • Labcorp Holdings 2022 EBIT was 1.437B, a 52.88% decline from 2021.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$147.1B
CVS Health (CVS)$76.8B
Elevance Health (ELV)$65.1B
Cencora (COR)$56.3B
DiDi Global (DIDIY)$25.7B
Natera (NTRA)$19B
BioMerieux (BMXMF)$17.7B
EUROFINS SCIENT (ERFSF)$15.9B
ICON (ICLR)$15.1B
CochLear (CHEOY)$13.4B
Solventum (SOLV)$12.9B
Medpace Holdings (MEDP)$12.6B
Revvity (RVTY)$12.2B
Viatris (VTRS)$11B
Avantor (AVTR)$9.7B
Sonic Healthcare (SKHHY)$9.1B
Charles River Laboratories (CRL)$8.7B
HealthEquity (HQY)$8.3B
Caris Life Sciences,�Inc (CAI)$7.5B
Amplifon S.p.A (AMFPF)$5.4B
Bausch + Lomb (BLCO)$5.1B
BrightSpring Health Services (BTSG)$3.6B
Sotera Health (SHC)$3.5B
Surgery Partners (SGRY)$2.7B
Organon (OGN)$2.7B
Concentras Parent (CON)$2.5B
Alignment Healthcare (ALHC)$2.3B
GeneDx Holdings (WGS)$2.3B
Progyny (PGNY)$2B
GoodRx Holdings (GDRX)$1.8B